Enrico Torre

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective.

Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: December 10, 2025

Building healthier communities: effectiveness and cost-sustainability of the ASL3 GENESIS program for chronic diseases prevention.

Building healthier communities: effectiveness and cost-sustainability of the ASL3 GENESIS program for chronic diseases prevention.

Journal: Aging clinical and experimental research

Published: November 13, 2025

Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus.

Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus.

Journal: Acta diabetologica

Published: July 25, 2025

Economic Evaluation of Once-Weekly Insulin Icodec from Italian NHS Perspective.

Economic Evaluation of Once-Weekly Insulin Icodec from Italian NHS Perspective.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: April 24, 2024

Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives.

Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: April 10, 2024

Hepatic encephalophathy: management and diagnostic therapeutic assistance path of Ligurian Local Health Company 3 (ASL3).

Hepatic encephalophathy: management and diagnostic therapeutic assistance path of Ligurian Local Health Company 3 (ASL3).

Journal: Minerva medica

Published: March 23, 2023

New perspectives in management of diabetes in long-term care facilities.

New perspectives in management of diabetes in long-term care facilities.

Journal: Minerva endocrinology

Published: January 31, 2023

Metabolic syndrome and alcohol consumption as risk factors for liver disease: which border?

Metabolic syndrome and alcohol consumption as risk factors for liver disease: which border?

Journal: Minerva medica

Published: May 16, 2022

Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives.

Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: May 06, 2022

Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.

Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: March 30, 2021

Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II.

Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II.

Journal: Health services insights

Published: January 17, 2020

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study.

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: November 27, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026